AMARIN CORP PLC\UK Interest Payable, Current
AMARIN CORP PLC\UK (AMRN) had Interest Payable, Current of $14.67 million as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2014-08-07
- 2014-06-30: Interest Payable, Current $14.67M.
- 2014-03-31: Interest Payable, Current $12.57M.
- 2013-12-31: Interest Payable, Current $12.97M.
- 2013-09-30: Interest Payable, Current $10.90M.
| Period end | Interest Payable, Current |
|---|---|
| 2014-06-30 | $14.67M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $12.57M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $12.97M 10-Q · filed 2014-08-07 |
| 2013-09-30 | $10.90M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $9.55M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $4.65M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.52M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |